Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial [Phase 3]
A Phase 3 trial (IRIS-trial) is evaluating iron administration to improve recovery after surgery with blood loss and is currently recruiting…
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW) [Phase 4]
The SPARROW trial compares standard versus prolonged antibiotic prophylaxis after pancreatoduodenectomy for pancreatic cancer and is current…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations [Phase 2]
Phase 2 clinical trial evaluating olaparib in combination with durvalumab for metastatic pancreatic cancer with DNA damage repair gene alter…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 [NA]
This clinical trial evaluates whether hepatotoxicity and neurotoxicity from oxaliplatin correlate with blood levels of HMGB1 in patients wit…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Phase IIT Trial of SNA014 [EARLY_Phase 1]
Early-phase trial update for SNA014 by SmartNuclide Biopharma targeting gastric and gastroesophageal junction adenocarcinomas; the study is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies [EARLY_Phase 1]
Notes an early Phase 1 trial of BGT007 for recurrent or refractory gastrointestinal cancers, including colorectal and pancreatic cancers, wh…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab to modulate the gut microbiome after chemotherapy in resectable pancreatic cancer. The study is cur…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics [NA]
Clinical trial registry entry describing an ongoing targeted-agent evaluation in digestive cancers in China based on molecular characteristi…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: AI-Assisted Non-Contrast CT for Multi-Cancer Screening [NA]
An ongoing study evaluating AI-assisted non-contrast CT for multi-cancer screening is currently recruiting, covering several cancers includi…
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Pharmacotyping of Pancreatic Patient-derived Organoids
This clinical trial update describes pharmacotyping of pancreatic cancer patient-derived organoids to guide personalized therapy. The study …
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) [NA]
Clinical trial update describing a study focusing on patient-reported outcomes in advanced pancreatic cancer or non-small cell lung cancer t…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Clinical trial update on detecting tumor cells and tumor DNA in blood, urine, and bone marrow of patients with solid cancers; the study is c…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A clinical trial update describing the investigation of Antroquinonol in combination with standard of care for first-line metastatic pancrea…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating Tg01 Vaccine with QS-21 Stimulon, with or without balstilimab, as maintenance therapy after adjuvant chemo…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients [Phase 1]
A Phase 1 trial evaluating stereotactic body radiotherapy (SBRT) with a PD-1 inhibitor for late-stage or recurrent pancreatic cancer has bee…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
A prospective study conducted by Fudan University evaluating the use of liquid biopsy for early detection of pancreatic cancer; recruitment …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors [Phase 1, Phase 2]
A Phase 1b/2a trial evaluating ENB003 in combination with pembrolizumab for various solid tumors, including melanoma, ovarian cancer, pancre…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer [Phase 3]
A Phase 3 trial evaluating perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer [Phase 3]
Phase 3 trial comparing liposomal irinotecan with oxaliplatin and S-1 versus gemcitabine with capecitabine as postoperative adjuvant therapy…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/2 study of CBP-1019, a bi-ligand-drug conjugate, in patients with advanced solid tumors incl…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: CTS2190 Phase I /II Clinical Study in Patients [Phase 1, Phase 2]
CTS2190 is a Phase 1/2 clinical study by CytosinLab Therapeutics evaluating CTS2190 in solid tumors, including pancreatic cancer, non-small …
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: 22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions [NA]
A clinical trial evaluating 22G Adapt Needle Biopsy versus standard fine-needle aspiration for endoscopic ultrasound-guided sampling of soli…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Exercise and Nutrition to Improve Pancreatic Cancer Outcomes [NA]
This entry reports a University of Oklahoma-sponsored clinical trial evaluating exercise and nutrition to improve outcomes for pancreatic ca…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 1]
Phase 1 study MT-601 in locally advanced unresectable or metastatic pancreatic cancer; study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling [NA]
A completed clinical trial evaluating genetic counseling augmented with an educational video or pamphlet versus traditional counseling metho…